Results 131 to 140 of about 260,495 (313)

Harnessing viral footprints in circulating free DNA (cfDNA) for early cancer detection: A focus on liquid‐biopsy‐based screening

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Viral infections play a significant role in cancer development, making detecting viral signatures a promising approach for early cancer diagnosis. Circulating free DNA (cfDNA), released into the bloodstream by tumors and other cells, has emerged as a powerful biomarker for non‐invasive cancer screening.
Richard Donkor Amponsah   +4 more
wiley   +1 more source

Long‐term human papillomavirus genotype‐specific risk of cervical high‐grade intraepithelial lesion and cancer—By age group and triage cytology

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Human papillomavirus (HPV) testing has revolutionized cervical cancer screening. Nonetheless, its optimal use for distinguishing between high‐ and low‐risk infections to leverage screening benefits remains to be established. Here, long‐term HPV genotype‐specific risk of precancerous cervical intraepithelial neoplasia grade 2 or higher was ...
Maija Vahteristo   +6 more
wiley   +1 more source

Two brothers with human papillomavirus-positive oropharyngeal squamous cell carcinoma of the tonsil: A case report

open access: yesSAGE Open Medical Case Reports
Oropharyngeal squamous cell carcinoma is a distinct subtype of head and neck cancer that has become increasingly linked to human papillomavirus over the last four decades. Described is the case of two brothers diagnosed with human papillomavirus-positive
Marco DiBlasi   +5 more
doaj   +1 more source

Calibrating models in economic evaluation: a comparison of alternative measures of goodness of fit, parameter search strategies and convergence criteria.

open access: yes, 2011
BACKGROUND: The importance of assessing the accuracy of health economic decision models is widely recognized. Many applied decision models (implicitly) assume that the process of identifying relevant values for a model's input parameters is sufficient to
Karnon, Jonathan, Vanni, Tazio
core   +1 more source

Trends in cervical cancer incidence in the Netherlands: A join‐point and age–period–cohort analysis (1989–2023)

open access: yesInternational Journal of Cancer, EarlyView.
What's New? This ecological study of trends in cervical cancer incidence from 1989 to 2023 in the Netherlands indicates a positive impact of screening, with a steady decline over the years. However, incidence increased from 2003 to 2023, particularly among younger cohorts, aligning with reduced participation and the introduction of more sensitive, high‐
Kelly Melisa Castañeda   +5 more
wiley   +1 more source

Evaluation of targeted next‐generation sequencing for detection of HPV genotypes and sublineages in cervical liquid‐based cytology SurePath samples from the Danish screening program

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Human papillomavirus (HPV) assays currently used in cervical cancer screening detect genotypes without providing information on viral lineages and sublineages. However, genotype‐specific sublineages may have distinct risk profiles, which could be harnessed to further improve risk stratification.
Karoline Andersen   +8 more
wiley   +1 more source

The prognostic value of cell‐free DNA dynamics during chemoradiotherapy in squamous cell carcinomas of the anus

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Chemoradiotherapy is the standard treatment for squamous cell carcinoma of the anus (SCCA). Toxicities linked to chemoradiotherapy, however, can negatively impact the quality of life, and biomarkers to distinguish which patients will benefit from treatment are lacking.
Anne Vittrup Jakobsen   +4 more
wiley   +1 more source

Human papillomavirus infection of the esophagus. A clinicopathologic study with demonstration of papillomavirus antigen by the immunoperoxidase technique [PDF]

open access: bronze, 1985
Barbara Winkler   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy